Heparin Calcium Wockhardt Uk (Heparin Calcium)

Heparin Calcium Wockhardt UK is indicated for several antithrombotic purposes in clinical practice.

• Prevention and treatment of venous thromboembolism, including deep vein thrombosis and pulmonary embolism.
• Prophylaxis of deep vein thrombosis in patients undergoing major surgery or orthopedic procedures.
• Management of acute coronary syndromes such as unstable angina or myocardial infarction.
• Bridging anticoagulation for patients transitioning between oral anticoagulants.
• Use during extracorporeal circulation, such as cardiopulmonary bypass, to maintain anticoagulation.

Side effects of heparin calcium may vary in frequency and severity.

Common

• Minor bleeding at injection sites or from mucous membranes.
• Small bruising or hematoma formation around the administration area.
• Transient elevation of liver enzymes detected in laboratory tests.
• Mild thrombocytopenia that resolves without intervention.

Serious

• Major hemorrhage, including intracranial or gastrointestinal bleeding.
• Heparin‑induced thrombocytopenia (HIT) with a risk of new clot formation.
• Allergic reactions ranging from rash to anaphylaxis.
• Spinal or epidural hematoma when used near the central nervous system.
• Severe elevation of liver transaminases indicating hepatic injury.

When prescribing Heparin Calcium Wockhardt UK, clinicians should consider several safety factors.

• Assess patient history for bleeding disorders, recent surgery, or trauma.
• Monitor platelet counts regularly to detect heparin‑induced thrombocytopenia.
• Adjust dosing in patients with renal or hepatic impairment as needed.
• Use caution in pregnant women; although category B, benefits must outweigh potential risks.
• Avoid concurrent use with other anticoagulants or antiplatelet agents unless medically justified.
• Conduct baseline and periodic coagulation tests (e.g., aPTT) to guide therapy.

Heparin calcium can interact with various medications, influencing its anticoagulant effect.

Avoid

• Concurrent use of other anticoagulants such as warfarin, direct oral anticoagulants, or low‑molecular‑weight heparins without specialist supervision.
• Combination with potent antiplatelet drugs (e.g., clopidogrel, aspirin) that markedly increase bleeding risk.
• Administration with fibrinolytic agents (e.g., alteplase) due to additive hemorrhagic potential.

Use with caution

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may impair platelet function.
• Certain antibiotics (e.g., quinolones) that can enhance anticoagulant activity.
• Herbal supplements such as ginkgo biloba or garlic that possess mild antithrombotic properties.